You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

145

Showing 1 - 25 of 5,541
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bone Sarcoma, Dedifferentiated Chondrosarcoma, Giant Cell Tumor of Bone Trial in Houston (biological, drug, other)

Recruiting
  • Bone Sarcoma
  • +15 more
  • Aldesleukin
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 3, 2022

Ovarian Cancer Trial in Turku (KAND145, Placebo)

Not yet recruiting
  • Ovarian Cancer
  • Turku, Finland
    Clinical Research Services Turku - CRST Oy
Sep 26, 2023

Multiple Myeloma Trial in Stanford (MGTA-145, Plerixafor)

Completed
Has Results
  • Multiple Myeloma
  • Stanford, California
    Stanford University
Aug 17, 2022

Sickle Cell Disease Trial in Boston, Memphis (MGTA-145, Plerixafor)

Recruiting
  • Sickle Cell Disease
  • Bethesda, Maryland
  • +2 more
Nov 4, 2022

Chronic Lymphocytic Leukemia Trial in Boston (IPI-145, Fludarabine, Cyclophosphamide)

Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia
  • Boston, Massachusetts
  • +1 more
Mar 10, 2022

Hyperlipidemia, Mixed Dyslipidemia Trial in Denver (Evolocumab)

Completed
Has Results
  • Hyperlipidemia
  • Mixed Dyslipidemia
  • Evolocumab
  • Denver, Colorado
    Research Site
Nov 3, 2022

Drug-resistant Focal Seizure Trial (OnabotulinumtoxinA 145 UNT [Botox])

Not yet recruiting
  • Drug-resistant Focal Seizure
  • OnabotulinumtoxinA 145 UNT [Botox]
  • (no location specified)
Oct 31, 2022

Metastatic Triple Negative Breast Cancer Trial in New Haven (Tumor infiltrating lymphocytes (TIL) LN-145)

Recruiting
  • Metastatic Triple Negative Breast Cancer
  • Tumor infiltrating lymphocytes (TIL) LN-145
  • New Haven, Connecticut
    Yale School of Medicine
Jul 20, 2022

Related Donors Donating PBSC to a Family Member, Healthy Donors, Acute Myelogenous Leukemia Trial in United States (MGTA-145,

Terminated
  • Related Donors Donating PBSC to a Family Member
  • +4 more
  • MGTA-145
  • Plerixafor
  • Duarte, California
  • +7 more
Apr 13, 2022

Acute Kidney Injury, Renal Replacement Therapy Trial in Montpellier (Lowering sodium concentration dialysate, Highing sodium

Recruiting
  • Acute Kidney Injury
  • Renal Replacement Therapy
  • Lowering sodium concentration dialysate
  • Highing sodium concentration dialysate
  • Montpellier, France
    Uhmontpellier
Sep 16, 2022

Metastatic Melanoma, Squamous Cell Carcinoma of the Head and Neck, NSCLC Trial in Worldwide (Lifileucel, LN-145, Pembrolizumab)

Recruiting
  • Metastatic Melanoma
  • +2 more
  • Lifileucel
  • +5 more
  • La Jolla, California
  • +44 more
Dec 16, 2022

HIV Trial in New York, Philadelphia (gp145 C.6980 Vaccine, Placebo, Aluminum Hydroxide Adjuvant)

Completed
Has Results
  • HIV Infections
  • gp145 C.6980 Vaccine
  • +2 more
  • New York, New York
  • +2 more
Oct 6, 2021

Metastatic Non Small Cell Lung Cancer Trial in Canada, Netherlands, United States (LN-145)

Recruiting
  • Metastatic Non Small Cell Lung Cancer
  • LN-145
  • Duarte, California
  • +40 more
Oct 20, 2022

Type 2 Diabetes, Cardiovascular Diseases, Pharmacogenomic Drug Interaction Trial in Padova (Fenofibrate 145 mg, Placebo)

Recruiting
  • Type 2 Diabetes
  • +2 more
  • Fenofibrate 145 mg
  • Placebo
  • Padova, Padua, Italy
    University Hospital of Padova
Sep 13, 2022

Ovarian Cancer Trial (EC145, Pegylated Liposomal Doxorubicin (PLD/Doxil®/Caelyx®), )

Terminated
  • Ovarian Cancer
  • (no location specified)
Sep 24, 2021

Cervical Carcinoma Trial in Worldwide (LN-145, LN-145 + pembrolizumab)

Recruiting
  • Cervical Carcinoma
  • LN-145
  • LN-145 + pembrolizumab
  • Phoenix, Arizona
  • +39 more
Aug 16, 2022

HIV Trial in Kericho (Env-C Plasmid DNA, HIV Env gp145 C.6980 protein, Rehydragel®)

Active, not recruiting
  • HIV Infections
  • Env-C Plasmid DNA
  • +6 more
  • Kericho, Kenya
    Kenya Medical Research Institute/Walter Reed Project, Clinical R
Feb 25, 2022

Corona Virus Disease (COVID-19), Respiratory Distress Syndrome, SARS-CoV-2 Infection Trial in Ashkelon, Haifa, Nazareth (TriCor®

Recruiting
  • Corona Virus Disease (COVID-19)
  • +2 more
  • TriCor® 145mg tablets
  • +2 more
  • Ashkelon, Israel
  • +2 more
Feb 23, 2022

Healthy Trial in Lenexa (IPI-145 (duvelisib), IPI-145)

Completed
  • Healthy
  • Lenexa, Kansas
    (unnamed)
Mar 15, 2021

Klinefelter Syndrome Trial in Aurora (Fenofibrate 145 mg)

Not yet recruiting
  • Klinefelter Syndrome
  • Fenofibrate 145 mg
  • Aurora, Colorado
    University of Colorado - Anschutz Medical Campus
Aug 9, 2022

Kidney Stone, Nephrolithiasis, Urolithiasis Trial in Moscow (SP TFL RIRS with 145 mcm fiber, SP TFL RIRS with 200 mcm fiber,

Recruiting
  • Kidney Stone
  • +2 more
  • SP TFL RIRS with 145 mcm fiber
  • +2 more
  • Moscow, Russian Federation
    Institute for Urology and Reproductive Health, Sechenov Universi
Jul 21, 2021

Healthy Trial in Zuidlaren (IPI-145)

Completed
  • Healthy
  • Zuidlaren, Netherlands
    Pharmaceuticals Research Association (PRA)
Mar 15, 2021

Healthy Trial in Lenexa (IPI-145, Midazolam)

Completed
  • Healthy
  • Lenexa, Kansas
    PRA International
Mar 15, 2021

Healthy Trial in Lenexa (IPI-145, Rifampin)

Completed
  • Healthy
  • Lenexa, Kansas
    PRA International, Inc
Mar 15, 2021

Healthy Volunteers Trial in Zuidlaren (IPI-145, Placebo)

Completed
  • Healthy Volunteers
  • Zuidlaren, Netherlands
    PRA International
Mar 15, 2021